Hematology & Blood Cancer
Advertisement
Although oral chemotherapy is convenient, adherence and safety must be monitored, especially in older patients.
Infection, pain, and psychological distress can all adversely affect this patient population. What can be done?
Disability leave, loss of income, and poor career opportunities were all challenges for patients with chronic GVHD.
Enteral probiotics and prebiotics, along with vitamin D supplementation, may help prevent gut GVHD in AHSCT patients.
The treatment reduced the risk of aGVHD and cGVHD but did not improve non-relapse mortality or overall survival.
Using carfilzomib instead of bortezomib improved progression-free and overall survival and reduced toxicity.
The difference was significant, with patients who received AHSCT with residual clonal plasma cells having much lower OS.
Though attrition rates increased, they were lower than previously reported.
Four themes were identified from patient telephone interview responses that summarized the experience of living with MM.
Accelerated approvals will no longer be granted based on overall response rates in single-arm trials.
The approved dosing schedule for venetoclax is time-limited, but how many patients follow the schedule?
Though rare, CLL and CML sometimes occur sequentially or concurrently. But what is the mechanism behind the relationship?
In a currently enrolling trial, patients with CLL and NMSC will receive experimental treatment with nicotinamide.
Deborah Stephens, DO, presented the recommendations and algorithms for first-, second-, and third-line CLL/SLL therapy.
Graft-versus-host disease is the most life-threatening consequence of stem cell transplant, and nurses are urgently needed.
The benefits of mindfulness meditation are numerous and far-reaching. But can they help HSCT recipients with GVHD?
Certain species were predictive of not only the occurrence of GVHD, but also the severity.
Pruritus is considered a mild adverse event, but does it negatively affect quality of life?
A case series demonstrated the effectiveness of a novel trio for pediatric plasmacytic PTLD.
Adolescents and young adults face different challenges than older survivors of ALL. Can technology improve these challenges?
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.